Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Akynzeo for CINV in Endometrial Cancer
NCT06726291Phase 4Recruiting
- Sponsor
- Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano
- Start
- Feb 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of palonosetron in chemotherapy-induced nausea and vomiting (CINV), sponsored by Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano. Started Feb 2024; status: recruiting.
02
Drugs
palonosetron
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT06726291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06726291.